Biosetas - Company finances
|
EUR
|
2022
From: 2022-11-17
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | 780,748 | 972,185 | 169,571 |
| Profit before tax | - | 488,234 | -120,866 | 26,761 |
| Net profit | 0 | 414,999 | -120,866 | 26,761 |
| Equity | 2,500 | 417,498 | -38,416 | -11,655 |
| Liabilities | 0 | 154,479 | 726,924 | 432,272 |
| Non-current assets | 0 | 0 | 285,329 | 33,784 |
| Current assets | 2,500 | 571,977 | 403,179 | 386,661 |
| Total assets | 2,500 | 571,977 | 688,508 | 420,445 |
|
Taxes paid
|
||||
| STI taxes | - | 31,429 | 85,989 | - |
| Social insurance contributions | - | 3,564 | 15,700 | 875 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | +24.5% | -82.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 72.6% | -17.6% | 6.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 99.4% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 53.2% | -12.4% | 15.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 62.5% | -12.4% | 15.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.4 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 195,187 | 208,324 | 78,262 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biosetas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-02-25 | 5167.38 |
| 2026-02-06 | 2026-02-17 | 2594.76 |
| 2026-02-04 | 2026-02-05 | 2570.23 |
| 2026-01-16 | 2026-02-03 | 2572.62 |
| 2025-11-18 | 2025-11-27 | 751.06 |
| 2025-10-20 | 2025-10-22 | 1273.75 |
| 2025-10-17 | 2025-10-19 | 1204.97 |
| 2025-09-16 | 2025-10-16 | 991.63 |
| 2025-09-07 | 2025-09-15 | 527.75 |
| 2025-08-31 | 2025-09-03 | 527.75 |
| 2025-08-19 | 2025-08-29 | 527.99 |
| 2025-07-25 | 2025-07-31 | 391.47 |
| 2025-07-16 | 2025-07-24 | 467.27 |
| 2025-06-17 | 2025-06-25 | 370.19 |
| 2025-05-16 | 2025-05-20 | 283.19 |
| 2025-03-18 | 2025-03-27 | 467.27 |
| 2025-02-18 | 2025-02-23 | 874.89 |
| 2024-11-18 | 2024-11-21 | 1202.47 |
| 2024-10-16 | 2024-10-17 | 963.99 |
| 2024-07-24 | 2024-08-01 | 1770.53 |
| 2024-07-16 | 2024-07-23 | 1755.17 |
| 2024-07-03 | 2024-07-15 | 525.59 |
| 2024-06-18 | 2024-07-02 | 1399.47 |
| 2024-05-16 | 2024-05-21 | 1399.47 |
| 2024-04-25 | 2024-04-28 | 3.57 |
| 2024-04-23 | 2024-04-24 | 1403.04 |
| 2024-04-16 | 2024-04-22 | 1399.47 |
| 2024-02-19 | 2024-02-21 | 1477.08 |
| 2024-01-16 | 2024-01-24 | 155.66 |
Biosetas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-12-29 | 2025-12-29 | 11073.41 |
| 2025-12-23 | 2025-12-28 | 10312.87 |
| 2025-12-22 | 2025-12-22 | 10339.87 |
| 2025-12-20 | 2025-12-21 | 2397.94 |
| 2024-11-01 | 2024-11-17 | 0.91 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biosetas, UAB (code 306178906) is a Private Limited Liability Company operating in logistics service activities. In the latest financial year, 2025, revenue decreased to €169.6K from €972.2K in 2024 and €780.7K in 2023, indicating a strong decline in turnover over the past two years. Even so, the company returned to profit in 2025, posting net profit of €26.8K and a profit margin of 15.8%, after a loss of €120.9K in 2024 and net profit of €415.0K in 2023. Total assets at year-end 2025 were €420.4K, compared with €688.5K in 2024. Equity remained negative at -€11.7K, while liabilities stood at €432.3K, which points to a strained balance sheet position. Long-term assets amounted to €33.8K and short-term assets to €386.7K. The latest ratios show ROA of 6.4% and asset turnover of 0.40x; ROE and debt-to-equity should be read cautiously because equity was negative. Revenue per employee was €84.8K, and profit per employee was €13.4K.